MedPath

Breakfast replacement by a low-glycemic index liquid formula in patients with diabetes mellitus type 2.

Completed
Conditions
diabetes glycemic indexglycemische indexbreakfastontbijt
Registration Number
NL-OMON22156
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Brief Summary

Stenvers DJ, Schouten LJ, Jurgens J, Endert E, Kalsbeek A, Fliers E, Bisschop PH. <i> Breakfast replacement with a low-glycaemic response liquid formula in patients with type 2 diabetes: a randomised clinical trial. </i> British Journal of Nutrition (2014), 112, 504–512

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1. DM2;

2. Age 30-75y;

Exclusion Criteria

1. Use of any other anti-diabetic drug than metformin;

2. Acute or chronic metabolic disease (other than diabetes) that will impair metabolism or digestion and absorption of food, including gastrointestinal, hepatic or renal disease;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting and postprandial glucose and insulin concentrations.
Secondary Outcome Measures
NameTimeMethod
1. Body weight;<br /><br>2. HbA1c;<br /><br>3. Glucose tolerance (determined by an oral glucose tolerance test);<br /><br>4. Plasma lipid concentrations;<br /><br>5. Oxidative stress.
© Copyright 2025. All Rights Reserved by MedPath